Business Daily Media

Business Marketing

.

Novaliq and Jiangsu Hengrui Medicine Announce a Strategic Collaboration in Ophthalmology for the EyeSol(R)-based, Investigational Products NOV03 and CyclASol(R) in China

  • Written by ACN Newswire - Press Releases
Heidelberg, Germany, Nov 9, 2019 - (ACN Newswire) - Novaliq GmbH, a pharmaceutical company focusing on first- and best-in-class ocular therapeutics, and Jiangsu Hengrui Medicine Co., Ltd. (SSE: 600276), a fully integrated biopharmaceutical company based in China, announce today the closing of an exclusive license agreement to develop, manufacture

Read more //?#

Popular

Tech Entrepreneur Reveals How VR Will Change Social Media Shopping

In the coming months, consumers will step into virtual stores, try on clothes without changing a single outfit, and explore products in 3D without leaving the comfort of their homes. The lines between the physical and digital ...

CA ANZ responds to recent release of FASEA reforms

Chartered Accountants Australia and New Zealand (CA ANZ) welcomes the release of the Financial Adviser Standards and Ethics Authority’s (FASEA’s) draft legislation for five out of the seven standards.   With the next round of ...

Impact of Design on Consumer Experience and Brand Loyalty

The pandemic bred a wave of opportunistic entrepreneurs and as the impact of COVID-19 begins to lift, it is imperative for the economy that small businesses are not just surviving but are thriving. Quality design is one of the...